Inventor

PERRIN-NINKOVIC SOPHIE

US18 patents

⚠️ This page may combine multiple inventors who share the name “PERRIN-NINKOVIC SOPHIE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PERRIN-NINKOVIC SOPHIE

SIGNAL PHARM LLC

Heteroaryl compounds, compositions thereof, and methods of treatment therewith

Methods of treatment comprising the administration of heteroaryl compounds

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Methods of synthesis and purification of heteroaryl compounds

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Methods for treating or preventing cancer using Benzopyranone Compounds

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors

PERRIN-NINKOVIC SOPHIE

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway

CELGENE CORP

Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith

Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith

HARRIS ROY L

Methods of synthesis and purification of heteroaryl compounds

SIGNAL PHARMACEUTICAL LLC

Methods for treating or preventing metastatic cancer using benzopyranone compounds